LMAT
Published on 04/14/2026 at 02:16 pm EDT
Using a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas.
You may vote online or by phone instead of mailing this card.
Votes submitted electronically must be received by 11:59 p.m., Eastern Time, on June 1, 2026.
Online
Go to investorvote.com/LMAT or scan the QR code - login details are located in the shaded bar below.
Phone
Call toll free 1-800-652-VOTE (8683) within the USA, US territories and Canada
▼ IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.▼
Proposals - Our Board of Directors recommends that stockholders vote FOR all nominees in Proposal 1 and FOR Proposals 2 and 3.
A
Election of Directors:
01 - David B. Roberts 02 - John A. Roush
To approve, by a non-binding, advisory vote, the 2025 compensation paid to our named executive officers.
To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
Authorized Signatures - This section must be completed for your vote to count. Please date and sign below.
B
Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title.
Date (mm/dd/yyyy) - Please print date below. Signature 1 - Please keep signature within the box. Signature 2 - Please keep signature within the box.
2 2 D V
04A0EB
LeMaitre Vascular, Inc.
2026 Annual Meeting of Stockholders
June 2, 2026, 10:00 a.m. EDT
LeMaitre Vascular, Inc., 32 Third Avenue, Burlington, Massachusetts 01803
Upon arrival, please present this admission ticket and photo identification at the registration desk. If your shares are held in street name, you must also bring a letter or account statement showing that you were the beneficial owner of the shares as of April 6, 2026.
Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be Held on June 2, 2026.
The proxy statement, the notice of the annual meeting and our 2025 Annual Report to stockholders are available at investorvote.com/LMAT.
▼ IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE.▼
George W. LeMaitre and Dorian P. LeBlanc, or any of them, each with the power of substitution, are hereby authorized to represent and vote the shares of the undersigned, with all the powers which the undersigned would possess if personally present, at the Annual Meeting of Stockholders of LeMaitre Vascular, Inc. to be held on June 2, 2026 or at any postponement or adjournment thereof.
Shares represented by this proxy will be voted as directed by the stockholder. If no such directions are indicated, the Proxies will have authority to vote FOR David B. Roberts and FOR John A. Roush, FOR item 2 to approve, by a non-binding, advisory vote, the 2025 compensation paid to our named executive officers, and FOR item 3 to ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
In their discretion, the Proxies are authorized to vote upon such other business as may properly come before the meeting.
(Items to be voted appear on reverse side)
Non-Voting Items
C
Disclaimer
LeMaitre Vascular Inc. published this content on April 14, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 14, 2026 at 18:15 UTC.